National Institutes of Health, Bethesda, Maryland, USA
Funding for this conference was made possible, in large part, by 1 R13 MH095328-01 from:
National Institute of Mental Health (NIMH) National Institute on Drug Abuse (NIDA) National Institute on Alcohol Abuse and Alcoholism (NIAAA) National Institute of Neurological Disorders and Stroke (NINDS) National Institute on Aging (NIA) National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Gold Contributors
Eli Lilly and Company, Indianapolis, Indiana, USA
Silver Contributors
H. Lundbeck A/S, Copenhagen, Denmark
Bronze Contributors
Biotie Therapies Corp, South San Francisco, California, USA
F. Hoffmann-La Roche Ltd, Basel, Switzerland
International Society of Cerebral Blood Flow and Metabolism, Geneva, Switzerland
Johns Hopkins Medicine Brain Science Institute, Baltimore, Maryland, USA
PMOD Technologies Ltd, Zurich, Switzerland